371 related articles for article (PubMed ID: 12905551)
21. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
22. Operative and functional results of total mesorectal excision with ultra-low anterior resection in the management of carcinoma of the lower one-third of the rectum.
McAnena OJ; Heald RJ; Lockhart-Mummery HE
Surg Gynecol Obstet; 1990 Jun; 170(6):517-21. PubMed ID: 1693016
[TBL] [Abstract][Full Text] [Related]
23. Prediction of treatment outcome by CD44v6 after total mesorectal excision in locally advanced rectal cancer.
Peng J; Lu JJ; Zhu J; Xu Y; Lu H; Lian P; Cai G; Cai S
Cancer J; 2008; 14(1):54-61. PubMed ID: 18303484
[TBL] [Abstract][Full Text] [Related]
24. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma.
Peeters KC; Marijnen CA; Nagtegaal ID; Kranenbarg EK; Putter H; Wiggers T; Rutten H; Pahlman L; Glimelius B; Leer JW; van de Velde CJ;
Ann Surg; 2007 Nov; 246(5):693-701. PubMed ID: 17968156
[TBL] [Abstract][Full Text] [Related]
25. Experience of surgery for rectal cancer with total mesorectal excision in a general surgical practice.
Dowdall JF; Maguire D; McAnena OJ
Br J Surg; 2002 Aug; 89(8):1014-9. PubMed ID: 12153627
[TBL] [Abstract][Full Text] [Related]
26. Immediate radical resection after local excision of rectal cancer: an oncologic compromise?
Hahnloser D; Wolff BG; Larson DW; Ping J; Nivatvongs S
Dis Colon Rectum; 2005 Mar; 48(3):429-37. PubMed ID: 15747069
[TBL] [Abstract][Full Text] [Related]
27. Surgical outcomes after total mesorectal excision for rectal cancer.
Chiappa A; Biffi R; Bertani E; Zbar AP; Pace U; Crotti C; Biella F; Viale G; Orecchia R; Pruneri G; Poldi D; Andreoni B
J Surg Oncol; 2006 Sep; 94(3):182-93; discussion 181. PubMed ID: 16900534
[TBL] [Abstract][Full Text] [Related]
28. Population-based study of factors influencing occurrence and prognosis of local recurrence after surgery for rectal cancer.
Manfredi S; Benhamiche AM; Meny B; Cheynel N; Rat P; Faivre J
Br J Surg; 2001 Sep; 88(9):1221-7. PubMed ID: 11531871
[TBL] [Abstract][Full Text] [Related]
29. The effect of circumferential tumor location in clinical outcomes of rectal cancer patients treated with total mesorectal excision.
Lee SH; Hernandez de Anda E; Finne CO; Madoff RD; Garcia-Aguilar J
Dis Colon Rectum; 2005 Dec; 48(12):2249-57. PubMed ID: 16400512
[TBL] [Abstract][Full Text] [Related]
30. Almost all five year disease free survivors are cured following rectal cancer surgery, but longer term follow-up detects some late local and systemic recurrences.
Moore E; Heald RJ; Cecil TD; Sharpe GD; Sexton R; Moran BJ
Colorectal Dis; 2005 Jul; 7(4):403-5. PubMed ID: 15932567
[TBL] [Abstract][Full Text] [Related]
31. Adjuvant chemotherapy with uracil-tegafur for pathological stage III rectal cancer after mesorectal excision with selective lateral pelvic lymphadenectomy: a multicenter randomized controlled trial.
Akasu T; Moriya Y; Ohashi Y; Yoshida S; Shirao K; Kodaira S;
Jpn J Clin Oncol; 2006 Apr; 36(4):237-44. PubMed ID: 16675478
[TBL] [Abstract][Full Text] [Related]
32. Macroscopic assessment of mesorectal excision in rectal cancer: a useful tool for improving quality control in a multidisciplinary team.
García-Granero E; Faiz O; Muñoz E; Flor B; Navarro S; Faus C; García-Botello SA; Lledó S; Cervantes A
Cancer; 2009 Aug; 115(15):3400-11. PubMed ID: 19479978
[TBL] [Abstract][Full Text] [Related]
33. Is postoperative radiotherapy useful for the rectal carcinoma in the era of total mesorectal excision?
Suh KW; Kim BW; Chun M; Lim HY
Hepatogastroenterology; 2002; 49(44):399-403. PubMed ID: 11995460
[TBL] [Abstract][Full Text] [Related]
34. Outcomes of resection of stage IV rectal cancer with mesorectal excision.
Law WL; Chu KW
J Surg Oncol; 2006 Jun; 93(7):523-8. PubMed ID: 16705728
[TBL] [Abstract][Full Text] [Related]
35. Depth of mesorectal invasion has prognostic significance in T3N0 low rectal cancer.
Tokoro T; Okuno K; Hida J; Ishimaru E; Ueda K; Yoshifuji T
Hepatogastroenterology; 2009; 56(89):124-7. PubMed ID: 19453042
[TBL] [Abstract][Full Text] [Related]
36. Anastomotic leakage after curative anterior resection results in a higher prevalence of local recurrence.
Bell SW; Walker KG; Rickard MJ; Sinclair G; Dent OF; Chapuis PH; Bokey EL
Br J Surg; 2003 Oct; 90(10):1261-6. PubMed ID: 14515297
[TBL] [Abstract][Full Text] [Related]
37. Local recurrence following surgical treatment for carcinoma of the lower rectum.
Polglase AL; Grodski SF; Tremayne AB; Chee JB; Bhathal PS
ANZ J Surg; 2004 Sep; 74(9):745-50. PubMed ID: 15379800
[TBL] [Abstract][Full Text] [Related]
38. Optimal preoperative assessment and surgery for rectal cancer may greatly limit the need for radiotherapy.
Simunovic M; Sexton R; Rempel E; Moran BJ; Heald RJ
Br J Surg; 2003 Aug; 90(8):999-1003. PubMed ID: 12905555
[TBL] [Abstract][Full Text] [Related]
39. Long-term wound advantages of the laparoscopic approach in rectal cancer.
Laurent C; Leblanc F; Bretagnol F; Capdepont M; Rullier E
Br J Surg; 2008 Jul; 95(7):903-8. PubMed ID: 18551506
[TBL] [Abstract][Full Text] [Related]
40. Impact of a surgical training programme on rectal cancer outcomes in Stockholm.
Martling A; Holm T; Rutqvist LE; Johansson H; Moran BJ; Heald RJ; Cedermark B
Br J Surg; 2005 Feb; 92(2):225-9. PubMed ID: 15609382
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
